AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own 3M today, you need to believe that its innovation engine and operational fixes can offset legal, environmental and macro headwinds, while PFAS liabilities remain the core overhang. The latest news around AI-enabled design tools and board changes does not materially alter that picture in the very near term, but it could shape confidence in execution, which is critical as investors weigh a turnaround story against litigation, portfolio complexity and slower expected revenue growth.
Among the recent developments, the completion of US$2,864.07 million in share repurchases under the 2025 buyback program stands out. It sits alongside continued dividends, including the US$0.78 per share Q1 2026 payout, as part of 3M’s broader capital return approach at a time when investors are watching how free cash flow is balanced against ongoing PFAS settlements, operational investments and the push into AI-enabled tools that aim to support product and margin ambitions.
Yet, against this progress, investors should still be aware of the unresolved PFAS litigation risk and how it could eventually affect free cash flow...
Read the full narrative on 3M (it's free!)
3M's narrative projects $26.1 billion revenue and $4.7 billion earnings by 2028.
Uncover how 3M's forecasts yield a $177.32 fair value, in line with its current price.
Some of the lowest ranked analysts take a more cautious view, assuming roughly flat revenue near US$25.1 billion and slower earnings progress, so you should recognise how differently others weigh PFAS liabilities compared with the potential upside from 3M’s AI-enabled design push and board refresh, and consider how both narratives might shift as the dust settles on this news.
Explore 6 other fair value estimates on 3M - why the stock might be worth as much as 27% more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com